Pharmacological and nonpharmacological interventions for children with ADHD
2023 updated
Recommendation(s)
Non-specialized health care providers at the secondary level should consider initiating parent education/training for a child who has been diagnosed with attention-deficit hyperactivity disorder (ADHD). Initial interventions may include cognitive-behavioural therapy and social skills training if feasible.
Strength of recommendation: CONDITIONAL
Certainty of evidence: MODERATE
For children 6 years old and above and adolescents who have an attention deficit hyperactivity disorder (ADHD) diagnosis, methylphenidate may be considered provided that:
- ADHD symptoms are still causing persistent significant impairment in at least one domain of functioning (education, interpersonal relationships, occupation), after the implementation of environmental modifications in schools, at home or in other relevant settings;
- A careful assessment of the child/adolescent has been conducted;
- The child/adolescent and the caregivers, as appropriate, have been informed about ADHD treatment options and supported in supported decision-making;
- Methylphenidate prescription is made by, or in consultation with, a specialist.
Strength of recommendation: CONDITIONAL
Certainty of evidence: LOW
[2012]
Recommendation(s)
Non-specialized health care providers at the secondary level should consider initiating parent education/training before starting medication for a child who has been diagnosed as suffering from attention-deficit hyperactivity disorder (ADHD). Initial interventions may include cognitive-behavioural therapy and social skills training if feasible.
Strength of recommendation: CONDITIONAL
Quality of the evidence: MODERATE
Methylphenidate may be considered, when available, after a careful assessment of the child, preferably in consultation with relevant specialist and taking into consideration the preferences of parents and children. Children receiving methylphenidate should be maintained under close clinical monitoring for improvement in symptoms and prevention of adverse effects. Care and support should be provided for the parents, if needed.
Strength of recommendation: CONDITIONAL
Quality of the evidence: MODERATE